Literature DB >> 2161815

Chemo-radioresistance of small cell lung cancer cell lines derived from untreated primary tumors obtained by diagnostic bronchofiberscopy.

Y Tanio1, M Watanabe, T Inoue, I Kawase, T Shiraska, T Ikeda, H Hara, T Masuno, S Saito, K Kawano.   

Abstract

New cell lines of small cell lung cancer (SCLC) were established from specimens of untreated primary tumors biopsied by diagnostic bronchofiberscopy. The advantage of this method was ease of obtaining specimens from lung tumors. Establishment of cell lines was successful with 4 of 13 specimens (30%). Clinical responses of the tumors showed considerable variation, but were well correlated with the in vitro sensitivity of the respective cell lines to chemotherapeutic drugs and irradiation. One of the cell lines was resistant to all drugs tested and irradiation, while another was sensitive to all of them. Although the acquired resistance of SCLC is the biggest problem in treatment, the natural resistance to therapy is another significant problem. Either acquired or natural, resistance mechanisms of SCLC may be elucidated by the use of such cell lines derived from untreated tumors. This method and these SCLC cell lines are expected to be useful for the serial study of biologic and genetic changes of untreated and pre-treated tumors, or primary and secondary tumors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161815      PMCID: PMC5918028          DOI: 10.1111/j.1349-7006.1990.tb02563.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


small cell lung cancer no change complete response partial response progressive disease monoclonal antibody
  38 in total

1.  Measurement of cell growth in tissue culture with a phenol reagent (folin-ciocalteau).

Authors:  V I OYAMA; H EAGLE
Journal:  Proc Soc Exp Biol Med       Date:  1956-02

2.  Changes in morphologic and biochemical characteristics of small cell carcinoma of the lung. A clinicopathologic study.

Authors:  M D Abeloff; J C Eggleston; G Mendelsohn; D S Ettinger; S B Baylin
Journal:  Am J Med       Date:  1979-05       Impact factor: 4.965

3.  Assessment of endoscopically visible bronchial carcinomas.

Authors:  N Martini; P M McCormick
Journal:  Chest       Date:  1978-05       Impact factor: 9.410

4.  Characterization of two cell lines with distinct phenotypes established from a patient with small cell lung cancer.

Authors:  G Bepler; G Jaques; K Havemann; A Koehler; B E Johnson; A F Gazdar
Journal:  Cancer Res       Date:  1987-04-01       Impact factor: 12.701

5.  Translocation of immunoglobulin VH genes in Burkitt lymphoma.

Authors:  J Erikson; J Finan; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

6.  Expression of a multidrug resistance gene in human cancers.

Authors:  L J Goldstein; H Galski; A Fojo; M Willingham; S L Lai; A Gazdar; R Pirker; A Green; W Crist; G M Brodeur
Journal:  J Natl Cancer Inst       Date:  1989-01-18       Impact factor: 13.506

7.  Human small-cell lung cancers show amplification and expression of the N-myc gene.

Authors:  M M Nau; B J Brooks; D N Carney; A F Gazdar; J F Battey; E A Sausville; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

8.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

Authors:  M M Nau; B J Brooks; J Battey; E Sausville; A F Gazdar; I R Kirsch; O W McBride; V Bertness; G F Hollis; J D Minna
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

9.  A panel of human lung carcinoma lines: establishment, properties and common characteristics.

Authors:  G M Duchesne; J J Eady; J H Peacock; M F Pera
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

10.  A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancer.

Authors:  Y Taya; K Hosogai; S Hirohashi; Y Shimosato; R Tsuchiya; N Tsuchida; M Fushimi; T Sekiya; S Nishimura
Journal:  EMBO J       Date:  1984-12-01       Impact factor: 11.598

View more
  5 in total

1.  Two monoclonal antibodies against small-cell lung cancer show existence of synergism in binding.

Authors:  S Saito; T Inoue; I Kawase; H Hara; Y Tanio; I Tachibana; S Hayashi; M Watanabe; M Matsunashi; T Osaki
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines.

Authors:  M Heenan; K Kavanagh; A Redmond; M Maher; E Dolan; P O'Neill; M Moriarty; M Clynes
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

3.  Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.

Authors:  Y Oji; H Ogawa; H Tamaki; Y Oka; A Tsuboi; E H Kim; T Soma; T Tatekawa; M Kawakami; M Asada; T Kishimoto; H Sugiyama
Journal:  Jpn J Cancer Res       Date:  1999-02

4.  Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas.

Authors:  S Moriuchi; K Shimizu; Y Miyao; T Hayakawa
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

5.  High sensitivity to peripheral blood lymphocytes and low HLA-class I antigen expression of small cell lung cancer cell lines with diverse chemo-radiosensitivity.

Authors:  Y Tanio; M Watanabe; T Osaki; I Tachibana; I Kawase; T Kuritani; S Saito; T Masuno; N Kodama; K Furuse
Journal:  Jpn J Cancer Res       Date:  1992-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.